Inotek starts off 2017 with a PhIII failure for lead drug, shares crater
The New Year in biotech got started this morning in just the same style it ended 2016; with a small biotech reporting a late-stage …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
